Recruiting

Observational Study

Sponsor:

The Cleveland Clinic

Code:

NCT00921986

Conditions

Arrhythmias, Cardiac

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Biorepository of blood and or tissue samples from patients presenting with cardiac arrhythmia syndromes.

Conditions

Arrhythmias, Cardiac

Study ID

NCT00921986

Start date

Mar, 2009

Status verified date

Aug, 2025

Completion date

Dec, 2035

Anticipated

Primary completion date

Dec, 2035

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Male or female at least 18 years old
  • Subjects with a history of or current cardiac arrhythmia, family members of subjects with cardiac arrhythmias, or no cardiac arrhythmia if a Control Subject.

Exclusion Criteria:

  • Subjects previously enrolled in the Arrhythmia BioBank

Study Design

Enrollment

2000 participants

Anticipated

Interventions and Outcome Measures

Arms

Arrhythmias

Patients with arrhythmias

Control Subjects

Subjects that do not have a history of cardiac arrhythmias.

Primary outcome measure

  • Genetic variants associated with arrhythmias [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Locations

Cleveland Clinic Foundation

Recruiting

Cleveland, Ohio, United States, 44195

Principal Investigator:

Mina K. Chung, MD

More Information

Sponsor

The Cleveland Clinic

Last update posted

Sep 10, 2025

Last verified

Aug, 2025

Keywords

  • genetics
  • biorepository
  • cardiac death
  • atrial fibrillation
  • ventricular fibrillation
  • ventricular tachycardia
  • supraventricular tachycardias
  • premature ventricular complexes
  • premature atrial complexes
  • atrioventricular and intraventricular blocks
  • sinus node dysfunction
  • syncope
  • vasovagal reactivity
  • postural orthostatic tachycardia syndrome

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Cleveland Clinic on 2025-09-10.